Skip to main content

Published locations for Dinutuximab combination therapy becomes first approval for high-risk neuroblastoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dinutuximab combination therapy becomes first approval for high-risk neuroblastoma

User login

  • Reset your password
  • /content/dinutuximab-combination-therapy-becomes-first-approval-high-risk-neuroblastoma
  • /jcso/article/103646/gastroenterology/dinutuximab-combination-therapy-becomes-first-approval-high
  • /hematology-oncology/article/103646/gastroenterology/dinutuximab-combination-therapy-becomes-first